---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-091905"
form_type: "8-K"
ticker: "PFSA"
cik: "0001859807"
company_name: "Profusa, Inc."
filed_at: "2026-08-20T12:32:30+00:00"
generated_at: "2026-08-20T12:35:07.501126+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Profusa Q2 net loss $8.8M; cash $719K; progress on G3 option

## Summary
- Net loss Q2 2026 $(8.8)M vs $(2.2)M year-ago; six-month loss $(12.2)M vs $(5.1)M.
- Cash at June 30 $719K; total assets $1.0M; stockholders' deficit $(27.1)M.
- Debt/liability holders executed $10.7M Series A Convertible Exchange Agreements; $4.57M converted to preferred.
- Borrowed $650K for working capital; 4:1 reverse stock split effective Aug 18, 2026.
- G3 audits expected by mid-September; combined company to operate as public diagnostics with CLIA labs.

## SEC filing metadata
- accession: 0001213900-26-091905
- form_type: 8-K
- ticker: PFSA
- cik: 0001859807
- company_name: Profusa, Inc.
- filed_at: 2026-08-20T12:32:30+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859807/000121390026091905/0001213900-26-091905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859807/000121390026091905/ea0302812-8k_profusa.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-091905
- JSON: https://secwatch.observer/filing/0001213900-26-091905.json
- Plain text: https://secwatch.observer/filing/0001213900-26-091905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.